Yingsheng Science (00209.HK) announced that on April 16, 2024, the company signed a memorandum of understanding with an independent third party (strategic partner) on strategic cooperation in the medical field. According to the memorandum of understanding, the two sides plan to establish a long-term strategic partnership to jointly develop business in the new medical aesthetic market, including entering the API market, with a view to achieving mutual benefit and common progress in technology in the medical field to meet the broader needs of human health.